DBV TECHNOLOGIES WKN: A1JWB7 ISIN: FR0010417345 Kürzel: DBV Forum: Aktien Thema: Hauptdiskussion

DBV Technologies Reports Third Quarter Financial Results and Business Update https://www.globenewswire.com/news-release/2022/11/03/2548369/0/en/DBV-Technologies-Reports-Third-Quarter-Financial-Results-and-Business-Update.html DBV Technologies Reports Third Quarter Financial Results and Business Update • DBV closes Q3 with a cash balance of $213M • DBV continues to practice budget discipline measures; cash used in operating activities decreased more than 35% between the nine months ended September 30, 2021, and 2022 • DBV continues to engage with the U.S. Food and Drug Administration (FDA) regarding the partial clinical hold on the VITESSE Phase 3 clinical study ...

DBV Technologies gibt bekannt, dass die FDA den teilweisen klinischen Stopp der Phase-3-Zulassungsstudie mit VITESSE aufgehoben hat

💃🤩

DBV Technologies Reports Full Year 2022 Financial Results and Business Update https://www.globenewswire.com/news-release/2023/03/02/2619881/0/en/DBV-Technologies-Reports-Full-Year-2022-Financial-Results-and-Business-Update.html

Rentnergang ☺️🙋‍♀️

🧚‍♀️

🎉

Läuft 😁

☕️

📌

Na bin ich heute gespannt 😄

🕊